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Surgical intervention for chronic deformities and ulcerations has become an important component in the management of
patients with diabetes mellitus. These patients are no longer relegated to wearing cumbersome braces or footwear for
deformities that might otherwise be easily corrected. Although surgical intervention in these often high-risk individuals
is not without risk, the outcomes are fairly predictable when patients are properly selected and evaluated. In this brief
review, we discuss the rationale and indications for diabetic foot surgery, focusing on the surgical decompression of
deformities that frequently lead to foot ulcers. ( J Vasc Surg 2010;52:44S-58S.)Foot deformities, including contracture of the
gastrocnemius-soleus complex, are clinically significant
risk factors that commonly lead to diabetic foot ulcer-
ation.1-3 In fact, deformity in association with peripheral
neuropathy and trauma were the three most common
component causes in the pathway leading to foot ulcer-
ation.3 Structural alterations in the architecture of the
foot often lead to abnormally high plantar foot pressures,
as well as increased dorsal, medial, or lateral pressures
when snugly fitting footwear is worn.4,5 These high
pedal pressures consequently place the foot at risk for
ulceration.6-8
Although deformities such as hammer toes and bun-
ions are quite common in the nondiabetic population, they
also frequently develop in persons with diabetes but with-
out significant consequence. It is the presence of peripheral
neuropathy, however, that confers the attendant risk for
ulceration in diabetic individuals. A recent study of patients
undergoing foot and ankle surgery has shown that diabetes
without complications imparts no greater risk for postop-
erative infection than that for persons without diabetes.
However, when diabetic patients with complications (in-
cluding neuropathy) were compared with those without
diabetes, there was a tenfold risk for developing postop-
erative infection.9 Although this study’s focus was on
postoperative infection in the foot and ankle, many
previous studies have demonstrated the importance of
neuropathy as a significant predictor of foot ulcer-
ation.3,7,10-12
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44SNeuropathy not only predisposes to foot ulcer in the
presence of deformity and trauma but can also lead to
the development of deformity in the diabetic foot.4,8,13 The
Charcot foot is the most classic example of a deformity
primarily related to peripheral neuropathy of any cause.14,15
Neuropathy affects the sensory nerves of the lower ex-
tremities and the motor as well as autonomic fibers.16-19
Consequently, motor neuropathy leads to muscle dys-
function, dynamic contractures, and even paresis (ie,
foot drop).
Ankle equinus, caused by a contracture of the
gastrocnemius-soleus muscle complex and Achilles’ ten-
don, is often found in patients with diabetes and has been
associated with high forefoot plantar pressures.20-22 The
clinical effects of motor neuropathy are also seen in the
form of intrinsic muscle atrophy.23 The “intrinsic mi-
nus” foot is typified by such atrophy on the dorsal
forefoot in concert with the development of hammer
toes or claw toes (Fig 1).8,24 In severe cases, the intrinsic
minus foot will develop a cavus appearance and associ-
ated high plantar pressures under the prominent meta-
tarsal heads.
Shoes are an important cause of trauma to the neuro-
pathic foot, especially in individuals with structural defor-
mity. Therefore, the provision of properly fitted therapeutic
footwear is considered a key component of an ulcer and
amputation prevention program.13,25-27 Unfortunately,
over-the-counter shoes often cannot accommodate severe
foot deformities, including high plantar pressures. In some
situations, custom footwear is indicated to protect severely
misshapen feet.
Nonetheless, any footwear is only as good as the pa-
tients’ adherence to wearing the shoes as prescribed. To
this end, even in the ulcerated foot where strict adherence
to off-loading modalities are critical, one study showed that
patients had poor compliance and wore the prescribed
off-loading devices only 28% of the time.28 Nonetheless,
several studies have shown that patients fitted with thera-
peutic footwear suffer significantly fewer primary or recur-
rent ulcerations compared with diabetic patients who were
not given such footwear.29-32
Surgical intervention should be considered when recur-
rent ulceration or preulcerative lesions develop despite
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ill-advised, corrective or reconstructive foot surgery has
assumed an important role in the management of pa-
tients with chronic or recurrent foot ulcerations.13,33-38
Of course, such patients need to be carefully selected and
evaluated to ensure that adequate vascularity is present
and that major comorbidities, including renal insuffi-
ciency, unstable cardiovascular disease, and congestive
heart failure, are adequately controlled. Because periph-
eral arterial disease (PAD) is often asymptomatic in
persons with diabetes, we follow the American Diabetes
Association recommendation that an ankle-brachial in-
dex (ABI) be measured in such persons who are aged
50 years.2,39 Furthermore, we routinely recommend
obtaining a preoperative ABI (with toe pressures and
waveforms) in diabetic patients with foot ulcers in the
absence of clearly bounding pulses.
In 2003, Armstrong and Frykberg38,40 revised a
risk-based scheme for classifying the types of foot surgery
performed in diabetic patients largely depending on the
presence of open wounds and their acuity. Fundamen-
tally, the classes of foot surgery are distinguished by their
progressive risks for subsequent proximal levels of ampu-
Fig 1. Intrinsic minus foot. Note the high arched, thin foot with
little muscle mass in this patient with advanced peripheral neurop-
athy. Flexible hammer toes (claw toes) usually accompany this
deformity as well.
Table. Classification of diabetic foot surgery40
● Class I: Elective. Reconstructive procedures on patients who
do not have loss of protective sensation (LOPS)
● Class II: Prophylactic. Reconstructive procedures performed
to reduce the risk of ulceration or reulceration in patients who
have LOPS and do not have a wound present
● Class III: Curative. Procedures performed to assist in healing
of open wounds
● Class IV: Emergent. Procedures performed to arrest or limit
progression of infectiontation (Table):● Elective surgery (class I) represents reconstructive pro-
cedures performed to correct deformities or high plan-
tar pressures in persons without neuropathy.
● Prophylactic (class II) procedures are those performed
in patients with neuropathy (loss of protective sensa-
tion) to reduce the risk of ulceration or recurrent
ulceration when no open wounds are present.
● Curative surgery (class III) is often performedwhenopen
wounds are present to effect a cure by removing under-
lyingbonyprominences (surgical decompression), osteo-
myelitis, or by draining underlying abscesses. Obviously,
such procedures are at higher risk for nonhealing or
infection than are the first two classes.
● Emergent procedures (class IV) are performed for
severe infections (wet gangrene, necrotizing fasci-
itis, etc) to control the progression of infection. As
the name implies, these procedures are performed
emergently and often consist of open amputations at
the foot level combined with fasciotomies of the leg.
Armstrong et al41 later validated this classification
scheme in subsequent risk for proximal amputation and
infection. They found a significant trend toward increasing
risk of ulceration/reulceration, postoperative infection, all-
level amputation, and major amputation with increasing
class of foot surgery (P  .01 for all complications). As
would be expected, the greatest frequency of major ampu-
tation was in class IV procedures.
Specific types of operations or procedures are not
restricted to single classes of surgery as described above.
To the contrary, many procedures are used in operations
performed across multiple foot surgery categories. For
example, a hammer toe repair might be performed as an
elective, prophylactic, or a curative procedure depending
on the presence of neuropathy and the presence or
Fig 2. Acquired second hammer toe after great toe amputation
with dorsal ulcer. This is easily treated by a digital arthroplasty
or joint resection with excision of the ulceration. A metatarso-
phalangeal joint release is also usually required for rigid
deformities.absence of an open wound (Fig 2) A tendo-Achilles’
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situations. A first ray amputation might be performed to
cure chronic osteomyelitis even in the absence of an open
wound (prophylactic), in the presence of a chronic drain-
ing ulcer (curative), or as an emergent procedure to
control the spread of an acute necrotizing infection. A
midfoot osteotomy or arthrodesis of an ulcerated Char-
cot deformity is commonly performed as a curative op-
eration (class III), but is just as frequently performed to
reconstruct a deformed nonulcerated foot and thereby
offer surgical decompression to reduce plantar pressures
(class II; Fig 3).15,42,43
This review will focus on those procedures commonly
used by foot and ankle surgeons to address deformities that
are causing abnormal pressure gradients. As already noted,
many of these procedures can be used in elective, prophy-
lactic, or curative situations depending on the presence (or
absence) of neuropathy or ulceration. Although we will not
discuss amputations or specific management of infection, a
brief discussion of those procedures used to correct the
Fig 3. Reconstruction for correction of unstable Char
deformity. B, A preoperative radiograph shows osteolysi
talectomy and fusion. D, Postoperative radiograph.Charcot foot will be presented.DIGITAL DEFORMITIES
Common digital deformities, such as hammer toe,
claw toe, and mallet toe, are known to increase pres-
sures and are associated with neuropathic ulceration.
Correcting the structural deformity with a resection
arthroplasty may augment healing and reduce the risk of
ulcer recurrence.44 Alternatively, a percutaneous flexor
tenotomy offers a less invasive approach and may afford
the necessary intrinsic pressure modulation to augment
healing.
Distal tip ulcers, in a flexible hammer toe, may
be managed with a flexor digitorum longus tenotomy. A
blade or 18-gauge needle is introduced 1 cm proximal to
the proximal plantar flexural crease of the toe (Fig 4). The
ankle is held in a dorsiflexed position with the patient
actively holding all toes in a flexed position. The toe is
manually straightened, and the blade is moved across the
taught tendon, making ease of the tenotomy. The long
extensor tendon will now hold the toe straight. A postop-
nkle. A, Preoperative clinical view demonstrates ankle
he talar dome. C, Circular external fixator in place aftercot a
s of terative shoe can be used for limited ambulation. Overex-
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tenotomy at a later date.
Laborde45 retrospectively reviewed 18 patients pre-
senting with plantar toe ulcers treated with a flexor tenot-
omy. All patients had a flexible claw toe deformity with
ulcers on the distal plantar aspect of the hallux or lesser toes.
The incision and the ulcer healed in all patients. Two
patients underwent a repeat procedure for ulcer recurrence
and remained ulcer free at 17 and 34 months.
Tamir et al46 retrospectively reviewed the outcomes of
14 patients (24 toes) treated with percutaneous flexor
tenotomies for a claw toe deformity to off-load the tip of
the toe for ulcer healing. The authors performed an oste-
oclasis in select patients to correct rigid contractures at the
proximal interphalangeal joint. All patients healed with no
significant complications noted.
Although the methodologic quality of both studies was
Fig 4. Flexor tenotomy. A, The toe is flexible and ulce
the patient is asked to dorsiflex the ankle and actively fle
and can easily be tenotomized as shown here with a #61
toes that have had flexor tenotomies. The fourth toe had
the office setting.poor, their results support the ability of a percutaneousflexor tenotomy of the hallux and lesser toes to heal neu-
ropathic toe ulceration secondary to toe contracture in
persons with diabetes.47
A rigid hammer toe is best treated with an arthroplasty
at the level of the distal or proximal interphalangeal joint.
However, a percutaneous flexor tenotomy may be at-
tempted in the nonflexible deformity before resorting to an
open arthroplasty. On those occasions where a hallux ulcer
is not due to a limitation of motion at the metatarsopha-
langeal joint (MTPJ), this same procedure can be used on
this digit (Fig 5).
LESSER METATARSALS
Neuropathic ulcerations under the metatarsal heads are
a challenging problem and may lead to infection and am-
the tip. B, Lidocaine is injected at the site of entry, and
he toes. This makes the long flexor tendon very taught,
r blade. No suture is needed. C, Shows all three middle
ction of osteomyelitis, 4 weeks postoperatively, done inr is at
x all t
Beave
reseputation.48 Various metatarsal procedures have been de-
y am
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tions.38,49,50 An isolated metatarsal osteotomy should be
considered for a chronic, nonundermining, nontunnel-
ing, ulcer below a specific metatarsal head. It can be
performed through a dorsal incision with a double-
action bone cutter or an oscillating saw. The osteotomy
can be done at the surgical or anatomic neck of the
metatarsal (Fig 6). A collar of bone may be removed if
shortening of the metatarsal is desired. Such procedures
are generally performed when the plantar ulceration does
not penetrate to bone.
A tunneling ulcer should be appropriately débrided
to remove all undermining. A metatarsal head resection
may be performed to assist in healing by internally
off-loading the ulcer (Fig 7). Armstrong et al51 evaluated
the outcomes of an isolated fifth metatarsal head resec-
tion for ulcerations beneath the fifth metatarsal head and
compared it with nonsurgical care. They reported more
rapid healing and a lower recurrence rate in the surgical
group.
The surgeon must be cognizant of maintaining a nearly
normal metatarsal parabola. The second, third, and fourth
metatarsals function as a single unit and any disruption in
metatarsal length or height may result in a transfer callus or
ulceration. If an ulcer occurs, further metatarsal osteotomy
may be necessary. Osteotomies should be performed on the
remaining two metatarsals, and if not, additional ulceration
is likely to develop over the remaining metatarsal, necessi-
Fig 5. Arthroplasty of the hallux for surgical off-loading
head of the proximal phalanx. B, Incision placement. C
tendon is repaired. D, The wound closed primarily. Earltating a third procedure. This scenario is especially likely tooccur after one of the metatarsal heads has been removed
due to infection.
Multiple metatarsal head resections or a panmetatar-
sal head resection may be considered for nonhealing
ulcers in the presence of an abnormal metatarsal parabola
(Fig 8).52 Hamilton et al48 proposed combining lesser
metatarsal head resections with gastrocnemius recession
and a peroneus longus-to-brevis tendon transfer in pa-
tients with chronic, neuropathic forefoot ulcerations. All
ulcers were located beneath lesser metatarsal heads, al-
lowing the authors to preserve the first MTPJ. They
adjunctively managed the equinus deformity with a gas-
trocnemius recession and alleviated pressure beneath the
first metatarsal with the peroneus longus-to-brevis trans-
fer. The authors reported ulcer healing in 10 patients
(100%), with no ulcer recurrence at a mean 14.2 months
of follow-up.48
KELLER ARTHROPLASTY
Limited range of motion at the MTPJ is a common
forefoot deformity that contributes to ulcer formation
beneath the hallux. This limitation in joint range of
motion leads to increased pressure on the hallux during
ambulation. Pressure reduction is essential and usually
consists of an external device to off-load the area.53 This
does not correct the underlying deformity, however. The
associated biomechanical abnormality still exists after the
off-loading device is removed, and ulcer recurrence may
chronic hallux ulceration. A, The ulcer is adjacent to the
head of the phalanx is removed, and the long extensor
bulation is possible with a postoperative shoe.of a
, Theoccur. Identifying and correcting the underlying struc-
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ulcer recurrence.
Armstrong et al54 compared the safety and efficacy of a
first MTPJ arthroplasty (Keller-type procedure) with non-
surgical management for wounds at the plantar aspect of
the hallux interphalangeal joint (Fig 9). They included 41
patients, with 21 undergoing a first MTPJ arthroplasty to
augment ulcer healing. Patients in the surgery group healed
significantly faster than patients in the nonsurgery group.
Care after healing was identical in both groups, and the
surgery group had fewer ulcer recurrences during the
6-month follow-up. There was a very high prevalence of
postoperative infections in the surgery group (40%), but
this was compared with the 38% of patients in the control
group who required treatment for infection during the
period of therapy. The results of this study suggest that a
first MTPJ arthroplasty is a safe and effective procedure in
the treatment of noninfected, nonischemic wounds be-
Fig 6. Metatarsal osteotomy, now performed in the offic
bone cutter, hemostat, and freer elevator as a probe. A, T
a large hemostat. B, A double-action bone cutter is intro
at the metatarsal neck level. D,Multiple osteotomies sho
and surgical neck of each metatarsal.neath the hallux.54FIRST MTPJ RESECTION
The excision of the first MTPJ should be considered
if the metatarsal head has osteomyelitis, after failed sesa-
moidectomy, or for a chronic ulcer probing to the joint
but with a viable hallux.38 The incision may incorporate
and excise the ulcer or be placed dorsally to avoid the
ulcer altogether. The incision is made directly to bone,
with no undermining of the soft tissue. The dissection is
at the level of the ligaments and periosteum. The meta-
tarsal is cut and beveled plantarly to reduce any bone
prominences. The base of the phalanx is removed as in a
Keller bunionectomy. Both sesamoids should be re-
moved because a fibrous union to the metatarsal stump
may occur if they are left and become a future source of
ulceration (Fig 10). This is also necessary in cases of open
joint involvement or infection, wherein the infected or
contaminated sesamoids will become a source for con-
ing when possible, can be done with simple instruments:
gh a dorsal incision, the metatarsal neck is grasped with
adjacent to the hemostat.C, The bone is osteotomized
ere are all in the proper location, between the anatomice sett
hrou
duced
wn htinued infection.
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Limited ankle joint mobility, as seen clinically as a tight
Achilles’-gastrocnemius-soleus complex, is a deforming
force and a causative factor in plantar forefoot ulcer-
ations.21 During normal gait, 10° of dorsiflexion at the
ankle is required, and anything less will increase plantar
pressures in the forefoot and impede healing of the wound.
To alleviate the pressure, several authors have suggested
percutaneous TAL.55-58 Armstrong et al21 confirmed that
Fig 7. A, Undermining ulceration that probes into d
standard metatarsal osteotomy. B, The ulcer is excised an
a proximal drain is acceptable as long as there is no active
non-weight bearing for 4 weeks.plantar pressures are reduced after percutaneous TAL. Linet al59 reported results of percutaneous TAL in 15 patients
with plantar forefoot ulcers that did not heal despite 9
weeks of total contact casting. All but one ulcer healed
(93%), with no ulcer recurrence noted after a mean 17.3-
month follow-up.
Mueller et al22 conducted a randomized control trial
comparing the combined treatment of total contact cast
and percutaneous TAL against a total contact cast alone.
Initial healing rates were similar in both groups, but the
issues (including bone or joint) is not appropriate for
adjacent metatarsal is removed.C, Primary closure with
s. The drain is pulled in 24 hours, and the patient is kepteep t
d the
sepsisignificant difference was noted when the ulcer recur-
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rence rate was 81% in the group treated with a total contact
cast alone compared with 38% in those treated with a total
contact cast and TAL. A gastrocnemius recession may be
used as an alternative for relief of forefoot pressure60 and
has also been described as an effective treatment for mid-
foot ulcers (Fig 11).60,61
CHARCOT FOOT
Charcot arthropathy, perhaps the most characteristic
deformity attributed to the diabetic foot, occurs in only
1% of the diabetic population as a whole and in approx-
imately 30% of individuals with peripheral neuropa-
thy.62-64 Originally described by Charcot as the pied
tabétiques in persons with tertiary syphilis,65 the Charcot
Fig 8. Pan metatarsal head resection. A, Failed metatars
amputation could be done, but the toes are viable. Surgic
approach; here, a dorsal approach is planned. C, Excision
several months after procedure.foot is now most commonly encountered in persons withdiabetes.66 Several studies have indicated that diabetic
patients with Charcot foot deformities have an increased
risk for ulceration and subsequent amputation and
higher mortality compared with diabetic persons with-
out this complication.67-69
The classic “rocker-bottom” deformity (Fig 12) is the
result of a collapse of themidfoot architecture generally due
to injury and continued weight bearing on the insensate
foot. With the continued stress of weight bearing, a vicious
cycle ensues that exaggerates local inflammation and leads
to more fractures, dislocations, and deformity.14,70 Abnor-
mally concentrated pressures develop in themidfoot during
ambulation on the deformed foot, and ulceration fre-
quently ensues.71When the ankle joint is the primary site of
involvement (Sanders-Frykberg pattern V),14 instability
geries with transfer ulcer subsecond. B, Transmetatarsal
loading can be accomplished through a dorsal or plantar
etatarsal head through a dorsal incision.D, Radiographal sur
al off-
of mand deformity become the most difficult problem to man-
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bracing.15,64,72
Conservative care for Charcot arthropathy has been the
traditional mainstay of treatment for this limb-threatening
disorder,14,64,72,73 but surgical management for Charcot
joints is not a recent evolution in our understanding of how
this entity can be approached. Although his report dealt
primarily with Charcot joints due to tabes dorsalis, Stein-
dler74 presented a series of surgical cases including subtalar
arthrodesis as early as 1931. Several other important surgi-
cal case series were published in the ensuing decades that
illustrated the efficacy of a surgical approach to this arthrop-
athy as well as its inherent difficulties and complica-
tions.75,76
Numerous descriptive studies have been published in
the last 20 years detailing various surgical techniques for the
Fig 9. A, Keller arthroplasty used as a curative procedur
shows the resection of the base of the proximal phalanx
noted 3 weeks after a Keller arthroplasty was performed.management of the deformed Charcot foot.15,43,77-82 Theindications for surgery are generally to provide a more
effective management strategy when conservative measures
have failed. Specifically, surgery is recommended for those
patients with recurrent ulceration (with or without infec-
tion), severe instability, or severe deformities not amenable
to footwear therapy alone.83Many surgical techniques have
been described, including simple plantar exostectomy with
or without TAL, midfoot realignment arthrodeses, hind-
foot arthrodeses, and ankle arthrodeses (Fig 13). A combi-
nation of procedures is most often required because Char-
cot deformities are usually multilevel. Although arthrodesis
using internal fixation is most often practiced, multipla-
nar external circular fixation using Ilizarov techniques (Fig
14) has been used with increasing frequency in recent
years.43,82,84 Regardless of technique, the goals of surgery
remain the same: establish a stable, plantigrade foot miti-
ulcer under a rigid hallux. B, A postoperative radiograph
llow for unrestricted dorsiflexion. C, Healed ulceratione for
to agating focal areas of increased pressure and shearing forces.
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pressures, healing of open ulcers can be augmented and the
risk of subsequent skin breakdown will be reduced.77 The
reader is referred to the referenced citations for specific
techniques of interest.
CONCLUSION
Surgical management of diabetic foot disorders is no
longer considered an unwarranted practice. To the con-
trary, surgery on the ulcerated or deformed foot has
assumed an increasingly important role in the manage-
Fig 10. First metatarsophalangeal joint resection. A
B, The joint is resected through a dorsal incision. The
joint. C, A radiograph shows the resection of the m
phalanx.ment of such disorders both in the United States andabroad. Nonetheless, these patients are indeed at a
higher risk for complications than their nondiabetic
counterparts, especially in those with peripheral neurop-
athy or ischemia. Careful patient selection and thorough
evaluation of the foot as well as attendant comorbidities
are the cornerstones of achieving successful results in
otherwise very complicated patients. Early and ostensibly
aggressive surgical intervention on the deformed foot
can obviate many months of unsuccessful conservative
care, especially when ulcer recidivism becomes the pri-
mary challenge. Although virtually all the procedures
chronic deep ulcer under the first metatarsal head.
or illustrates that the plantar ulcer penetrated into the
rsal head, both sesamoids, and the base of proximal, A
elevat
etataused in this setting are not exclusive to diabetic foot
deformity.
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healing of a plantar forefoot ulceration. B, An image taken 2 years
postoperatively demonstrates long-term ulcer healing.Fig 12. A rocker-bottom Charcot foot is shown with soft tissue
visualization of large plantar midfoot ulcer under the apex of the
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 12S Frykberg et al 55SFig 13. A, This chronic midfoot ulcer was treated with a simple exostectomy with tendo-Achilles’ lengthening.
B, Postoperative image shows a plantar incision that was closed primarily and reinforced with tape strips (tendo-
Achilles’ lengthening incision not shown).
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the postoperative period to ensure optimal outcomes in
these high-risk patients.
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